Hepatotoxicity of Immune Checkpoint Inhibitors: An Evolving Picture of Risk Associated With a Vital Class of Immunotherapy Agents

Liver International - United Kingdom
doi 10.1111/liv.13746
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents

Safety and Risk of Pharmacotherapy
2020English

Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data

International Journal of Cancer
Cancer ResearchOncology
2017English

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy With Immune Checkpoint Inhibitors

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
2018English

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

5) Management of Neurological Adverse Events Associated With Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Immune Checkpoint Inhibitors in the Treatment of Virus-Associated Cancers

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Immunology
AllergyImmunology
2019English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy